Christopher Twitty
CIK 1870121 · Chief Scientific Officer · last filed 2026-04-02
Christopher Twitty is a Chief Scientific Officer who has filed 3 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for SKYE, was dated Apr 2, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
3
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SKYE | Chief Scientific Officer | — | $0.79 | — | $0 | 2 | 2026-04-02 |
| ZyVersa Therapeutics, Inc. (LSPRW) Delisted | Director | — | $0.18 | — | $0 | 1 | 2022-03-10 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-02 | SKYE | Mixed | — | $0 | EDGAR |
| 2026-02-09 | SKYE | Grant (A) | — | $0 | EDGAR |
| 2022-03-10 | ZyVersa Therapeutics, Inc. (LSPRW) Delisted | Other (J) | — | $0 | EDGAR |